Syros Pharmaceuticals Inc.
SYRS:NASDAQ
Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches.
Streetwise Company Fact Sheet2024/11/15 11:17:14
(SYRS:NASDAQ)
Analyst coverage
| H.C. Wainwright & Co. — Andrew Fein |
Streetwise Reports Articles
| 12/06/2023 - View Article |
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
